Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-2-18
pubmed:abstractText
Fifteen patients with major depression, dysthymia, or anxiety disorder with depressed mood (DSM-IV diagnoses) and 16 controls received single oral doses of 0.5mg/kg metachlorophenylpiperazine (m-CPP), a 5-HT(2C) agonist, and 10 mg ipsapirone, a 5-HT(1A) agonist, according to double-blind, placebo-controlled, cross-over design. The groups' levels of cortisol, adrenocorticotrophic hormone (ACTH) and prolactin did not differ at baseline. Both 5-HT agonists significantly elevated cortisol, ACTH, and prolactin. The cortisol response to ipsapirone was significantly blunted in major depression and dysthymia patients. Neuroendocrine responses to m-CPP did not differ between groups, but m-CPP selectively increased profile of mood states (POMS) depression and tenseness scores in patients. No effects of ipsapirone on mood were found. However, ipsapirone impaired memory performance in controls, but tended to improve memory performance in patients. The results support the evidence for both hypothalamic and possibly hippocampal 5-HT(1A) receptor desensitisation and non-hypothalamic, 5-HT(2C) receptor sensitisation, probably fronto-cortical, in patients with major depression and dysthymia.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0893-133X
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
358-67
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed-meshheading:11850150-Adrenocorticotropic Hormone, pubmed-meshheading:11850150-Adult, pubmed-meshheading:11850150-Affect, pubmed-meshheading:11850150-Aging, pubmed-meshheading:11850150-Analysis of Variance, pubmed-meshheading:11850150-Cognition, pubmed-meshheading:11850150-Cross-Over Studies, pubmed-meshheading:11850150-Depression, pubmed-meshheading:11850150-Double-Blind Method, pubmed-meshheading:11850150-Female, pubmed-meshheading:11850150-Hormones, pubmed-meshheading:11850150-Humans, pubmed-meshheading:11850150-Hydrocortisone, pubmed-meshheading:11850150-Male, pubmed-meshheading:11850150-Middle Aged, pubmed-meshheading:11850150-Neurosecretory Systems, pubmed-meshheading:11850150-Prolactin, pubmed-meshheading:11850150-Receptors, Serotonin, pubmed-meshheading:11850150-Receptors, Serotonin, 5-HT1, pubmed-meshheading:11850150-Serotonin Receptor Agonists, pubmed-meshheading:11850150-Sex Characteristics
pubmed:year
2002
pubmed:articleTitle
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
pubmed:affiliation
Brain and Behaviour Institute, Department of Psychiatry and Neuropsychology, University Hospital, Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Wm.Riedel@Np.UniMaas.NL
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't